Acadia Healthcare (NASDAQ:ACHC – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday.
ACHC has been the subject of a number of other research reports. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Barclays dropped their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. Royal Bank of Canada reduced their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday, November 18th. Finally, KeyCorp started coverage on Acadia Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $70.22.
View Our Latest Analysis on Acadia Healthcare
Acadia Healthcare Stock Performance
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 EPS. As a group, equities research analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Acadia Healthcare
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. GAMMA Investing LLC raised its stake in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after acquiring an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Acadia Healthcare in the 2nd quarter valued at about $59,000. Covestor Ltd boosted its stake in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after buying an additional 1,018 shares during the period. DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare during the third quarter worth about $86,000. Finally, Assetmark Inc. increased its stake in shares of Acadia Healthcare by 66.1% during the third quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock worth $94,000 after buying an additional 591 shares during the period.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- The 3 Best Blue-Chip Stocks to Buy Now
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What is a Death Cross in Stocks?
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How to Invest in Insurance Companies: A Guide
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.